10
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Role of endothelial factors in the specific response of mouse tumour-feeding arterioles to stimulation of 5-HT1 receptors

Pages 365-371 | Published online: 03 Jul 2009

  • AUCH-SCHWELK, W. and VANHOUTTE, P. M., 1991, Endotheliumderived contracting factor released by serotonin in the aorta of the spontaneously hypertensive rat. American Journal of Hypertension, 4, 769-772.
  • CHESTER, A. H., ALLEN, S. P., TADJKARIMI, S. and YACOUB, M. H., 1993, Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Grailation, 87, 874-880.
  • CODY, W. L., DOHERTY, A. M., HE, J. X., DEPUE, P. L., RAPUNDALO, S. T., HINGORANI, G. A., MAJOR, T. C., PANEK, R. L., DUDLEY, D. T., HALBEN, S. J., LADOUCEUR, D., HILL, K. E., FLYNN, M. A. and REYNOLDS, E. E., 1992, Design of a functional hexapeptide antagonist of endothelin. Journal of Medicinal Chemistry, 35, 3301-3303.
  • CRUZ, M. A., GALLARDO, V., MIGUEL, P., CARRASCO, G. and GONZALEZ, C., 1997, Serotonin-induced vasoconstriction is mediated by thromboxane release and action in the human fetal-placental circulation. Placenta, 18, 197-204.
  • DAVIS, M. J., 1987, Determination of volumetric flow in capillary tubes using an optical Doppler velocimeter. Microvascular Research, 34, 223-230.
  • DENEKAMP, J., 1991, The current status of targeting tumour vasculature as a means of cancer therapy: an overview. International Journal of Radiation Biology, 60(1/2), 401-408.
  • DESCOMBES, J. J., DEVYS, M., LAUBIE, M. and VERBEUREN, T. J., 1993. Endothelial thromboxane production plays a role in the contraction caused by 5-hydroxytryptamine in rat basilar arteries. European Journal of Pharmacology, 243, 193-199.
  • DUBBIN, P. N., ZAMBETIS, M. and DUSTING, G. J., 1990, Inhibition of endothelial nitric oxide biosynthesis by Nnitro-L-arginine. Clinical and Experimental Pharmacology and Physiology, 17, 281-286.
  • GATMAITAN, Z., VARTICOVSKI, L., LING, L., MIKKELSEN, R., STEFFAN, A. M. and ARIAS, I. M., 1996, Studies on fenestral contraction in rat liver endothelial cells in culture. American Journal of Pathology, 148, 2027-2041.
  • HIRAKAWA, Y., KUGA, T., OHARA, Y., HATA, H., TOMOIKE, H. and T AKESHITA, A., 1995, Mechanisms of coronary hyperconstriction in response to serotonin induced by X-irradiation in miniature pigs: increased constructive response of medial smooth muscle. Heart Vessels, 10, 190-196.
  • ITO, A., EGASHIRA, K., KADOKAMI, T., FUKUMOTO, Y., TAKAYANAGI, T., NAKAIKE, R., KUGA, T., SUEISHI, K., SHIMOKAWA, H. and TAKESHITA, A., 1995, Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs. Circulation, 92, 2636-2644.
  • JAMES, G. M. and HODGSON, W. C., 1995, Potentiation by endothelin-1 of 5-hydroxytiyptamine responses in aortae from streptozotocin-diabetic rats: a role for thromboxane A2. British Journal of Pharmacology, 114, 1236-1240.
  • KOPIA, G. A., VALOCIK, R. E., TORPHY,T. J., CIESLINKSI, L. B, SARAU, H. M., FOLEY, J. J. and WASSERMAN, M. A., 1987, Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog. Journal of Pharmacology and Experimental Therapeutics, 241, 174-180.
  • LAMB, V. L., SCHWARTZ, A. J., ROHN, W. R. and KAISER, L., 1994, Cyclooxygenase inhibitors depress norepinephrine constriction of rat abdominal, but not thoracic, aorta. European Journal of Pharmacology, 256, 221-226.
  • LAMPING, K. G., 1997, Response of native and stimulated collateral vessels to serotonin. American Journal of Physiology, 272, H2409-H2415.
  • LIPOWSKY, H. H., KOVALCHECK, S. and ZWEIFACH, B. W., 1978, The distribution of blood theological parameters in the microvasculature of cat mesentery. Circulation Research, 43, 738-749.
  • MAGOLDA, R. L., RIPKA, W. C., GALBRAITH, W., JOHNSON, P. R. and RUDNICK, M. S., 1985, Novel synthesis of potent sitespecific phospholipase A2 inhibitors. In Prostaglandins, Leukotrienes, and Lipoxins, edited by J. M. Bailey (New York: Plenum Publishing Corp), pp. 669-675.
  • MARTIN, G. R., 1994, Vascular receptors for 5-hydroxytryptamine: distribution, function, and classification. Pharmacology and Therapeutics, 62, 283-324.
  • OKATANI, Y., TANIGUCHI, K. and SAGARA, Y., 1995, Amplifying effect of endothelin-1 on serotonin-induced vasoconstriction of human umbilical artery. American Journal of Obstetrics and Gynecobgy, 172, 1240-1245.
  • OZAKI, Y., OHASHI, T. and NIWA, Y., 1986, A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Biochemical Pharmacology, 35, 3481-3488.
  • PORSA, E., HARPER, M. J. K. and HERLIHY, J. T., 1989, Effects of preload and eicosanoid synthesis inhibition on rat aortic smooth muscle sensitivity. Prostaglandins Leukotrienes and Essential Fatty Acids, 38, 61-65.
  • REES, D. D., PALMER, R. M. J., HUDSON, H. F. and MONCADA, S., 1989, A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. British Journal of Pharmacology, 96, 418-424.
  • SIKORSKI, B. W., JAMES, G. M., GLANCE, S. D., HODGSON, W. C. and KING, R. G., 1993, Effect of endothelium on diabetesinduced changes in constrictor responses mediated by 5-hydroxytryptamine in rat aorta. Journal of Cardiovascular Pharmacology, 22, 423-430.
  • STENGEL, P. W. and SILBAUGH, S. A., 1989, Reversal of A23187-induced airway constriction in the guinea pig. Journal of Pharmacology and Experimental Therapeutics, 248, 1084-1090.
  • STUCKER, O., LAEMMEL, E., TEISSEIRE, B. and VICAUT, E., 1997, Specific response of mouse tumor-feeding arterioles to stimulation by 5-HT1 agonists. International Journal of Radiation Oncology, Biology, Physics, 37, 1125-1131.
  • STOCKER, O., VICAUT, E. and TEISSEIRE, B., 1991, Hyperresponsiveness to 5-HT2 agonists by tumour-feeding arterioles in mice: consequences for tumour growth. International Journal of Radiation Biology, 60, 237-241.
  • STOCKER, O., VICAUT, E. and TEISSEIRE, B., 1992, Specific response to 5-HT2 agonists by arterioles linked to Meth A tumors in mice. American Journal of Physiology, 262, H704-H709.
  • VALENTIN, J. P., BONNAFOUS, R. and JOHN, G. W., 1996, Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein. British Journal of Pharmacology, 119, 35-42.
  • VAN DIEST, M., VERBEUREN, T. J. and HERMAN, A. G., 1993, Vascular interaction between 5-hydroxytryptamine and 15-lipoxygenase metabolites of arachidonic acid. European Journal of Pharmacology, 231, 267-274.
  • WHITING, M. V. and CAMBRIDGE, D., 1995, Canine renovascular responses to sumatriptan and 5-carboxamidotryptamine: modulation through endothelial 5-HT,-like receptors by endogenous nitric oxide. British Journal of Pharmacology, 114, 969-974.
  • YANG, B. C. and MEHTA, J. L., 1994, Platelets increase the tone of quiescent rat aortic rings by release of serotonin and potentiate the subsequent contractile response to norepinephrine. Journal of Cardiovascular Pharmacology, 23, 387-394.
  • YOKOTA, Y., IMAIZUMI, Y., ASANO, M., MATSUDA, T. and WATANABE, M., 1994, Endothelium-derived relaxing factor released by 5-HT: distinct from nitric oxide in basilar arteries of normotensive and hypertensive rats. British Journal of Pharmacology, 113, 324-330.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.